R. van der Does

546 total citations
22 papers, 443 citations indexed

About

R. van der Does is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, R. van der Does has authored 22 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 6 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in R. van der Does's work include Blood Pressure and Hypertension Studies (9 papers), Cardiac pacing and defibrillation studies (7 papers) and Cardiac Imaging and Diagnostics (6 papers). R. van der Does is often cited by papers focused on Blood Pressure and Hypertension Studies (9 papers), Cardiac pacing and defibrillation studies (7 papers) and Cardiac Imaging and Diagnostics (6 papers). R. van der Does collaborates with scholars based in Germany, United Kingdom and Switzerland. R. van der Does's co-authors include Roxy Senior, Avijit Lahiri, Thomas Brückner, Sumit Basu, U. Raval, B. Ehmer, Martin Hund, Diethelm Messinger, Wilma D.J. Verhagen-Kamerbeek and Holger Stepan and has published in prestigious journals such as Circulation, PLoS ONE and The American Journal of Cardiology.

In The Last Decade

R. van der Does

22 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. van der Does Germany 11 320 87 84 73 61 22 443
DA Richards United States 10 153 0.5× 26 0.3× 10 0.1× 104 1.4× 10 0.2× 21 367
H Pirttiaho Finland 11 112 0.3× 66 0.8× 13 0.2× 52 0.7× 60 1.0× 22 415
Martin M.-T. Fuh Taiwan 16 236 0.7× 82 0.9× 75 0.9× 156 2.1× 15 0.2× 28 707
Ch. Schnack Austria 14 200 0.6× 28 0.3× 44 0.5× 53 0.7× 14 0.2× 20 500
Rafael Marín Spain 10 264 0.8× 85 1.0× 90 1.1× 61 0.8× 6 0.1× 12 404
Nicholas Alp United Kingdom 5 218 0.7× 220 2.5× 191 2.3× 74 1.0× 12 0.2× 6 591
Nicole Jachmann Germany 5 219 0.7× 9 0.1× 12 0.1× 29 0.4× 17 0.3× 5 388
Frida Liane Plavnik Brazil 13 256 0.8× 22 0.3× 12 0.1× 51 0.7× 30 0.5× 41 403
M.L. Muiesan Italy 13 389 1.2× 18 0.2× 19 0.2× 95 1.3× 36 0.6× 41 525
K McGarry Ireland 8 284 0.9× 15 0.2× 7 0.1× 83 1.1× 8 0.1× 12 377

Countries citing papers authored by R. van der Does

Since Specialization
Citations

This map shows the geographic impact of R. van der Does's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. van der Does with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. van der Does more than expected).

Fields of papers citing papers by R. van der Does

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. van der Does. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. van der Does. The network helps show where R. van der Does may publish in the future.

Co-authorship network of co-authors of R. van der Does

This figure shows the co-authorship network connecting the top 25 collaborators of R. van der Does. A scholar is included among the top collaborators of R. van der Does based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. van der Does. R. van der Does is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bosch, Ernesto, et al.. (2021). Early detection of pregnancy after IVF and embryo transfer with hyperglycosylated HCG versus Elecsys HCG+β assay. Reproductive BioMedicine Online. 44(2). 349–356. 3 indexed citations
2.
Klein, Evelyn, Dietmar Schlembach, A Ramoni, et al.. (2016). Influence of the sFlt-1/PlGF Ratio on Clinical Decision-Making in Women with Suspected Preeclampsia. PLoS ONE. 11(5). e0156013–e0156013. 58 indexed citations
3.
Hund, Martin, et al.. (2015). Influence of the sFlt-1/PlGF ratio on clinical decision-making in women with suspected preeclampsia – the PreOS study protocol. Hypertension in Pregnancy. 34(1). 102–115. 25 indexed citations
4.
5.
Khattar, Rajdeep, et al.. (2001). Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol. American Heart Journal. 142(4). 704–713. 40 indexed citations
6.
7.
Does, R. van der, et al.. (1999). Comparison of safety and efficacy of carvedilol and metoprolol in stable angina pectoris. The American Journal of Cardiology. 83(5). 643–649. 22 indexed citations
8.
9.
Does, R. van der, et al.. (1996). Comparison of the hemodynamic effects of metoprolol and carvedilol in hypertensive patients. Cardiovascular Drugs and Therapy. 10(2). 113–117. 13 indexed citations
10.
Senior, Roxy, et al.. (1992). Effects of Carvedilol on Ventricular Arrhythmias. Journal of Cardiovascular Pharmacology. 19(Supplement 1). S117–S121. 28 indexed citations
11.
Does, R. van der, et al.. (1992). Efficacy and Safety of Carvedilol in Comparison with Nifedipine Sustained-Release in Chronic Stable Angina. Journal of Cardiovascular Pharmacology. 19(Supplement 1). S122–S127. 12 indexed citations
12.
Nahrendorf, Wiebke, et al.. (1992). A Comparison of Carvedilol with a Combination of Propranolol and Isosorbide Dinitrate in the Chronic Treatment of Stable Angina. Journal of Cardiovascular Pharmacology. 19(Supplement 1). S114–S116. 14 indexed citations
13.
Sievert, H., Georgia C. Frey, Rainer Schräder, et al.. (1990). Influence of carvedilol and propranolol on coronary blood flow. European Journal of Clinical Pharmacology. 38(S2). S122–S124. 8 indexed citations
14.
Does, R. van der, et al.. (1990). Safety and antihypertensive efficacy of carvedilol and atenolol alone and in combination with hydrochlorothiazide. European Journal of Clinical Pharmacology. 38(S2). S143–S146. 9 indexed citations
15.
Does, R. van der, et al.. (1990). Efficacy and safety of carvedilol in comparison with atenolol in hypertensive patients pretreated with hydrochlorothiazide. European Journal of Clinical Pharmacology. 38(S2). S147–S152. 9 indexed citations
16.
Ehmer, B., et al.. (1988). Influence of Carvedilol on Blood Glucose and Glycohaemoglobin A1 in Non-Insulin-Dependent Diabetics. Drugs. 36(Supplement 6). 136–140. 23 indexed citations
17.
Lahiri, Avijit, et al.. (1988). Effects of Carvedilol on Left Ventricular Function in Essential Hypertension and Ischaemic Heart Disease1. Drugs. 36(Supplement 6). 141–143. 2 indexed citations
18.
Does, R. van der, et al.. (1987). Acute Hemodynamic Effects of the Vasodilating and β-Blocking Agent Carvedilol in Comparison to Propranolol. Journal of Cardiovascular Pharmacology. 10. S147–S150. 6 indexed citations
19.
Does, R. van der, et al.. (1987). Acute Hemodynamic Effects of the Vasodilating and β-Blocking Agent Carvedilol in Comparison to Propranolol. Journal of Cardiovascular Pharmacology. 10(Supplement). S147–S150. 7 indexed citations
20.
Does, R. van der, et al.. (1987). Acute Hemodynamic Effects of the Vasodilating and β-Blocking Agent Carvedilol in Comparison to Propranolol. Journal of Cardiovascular Pharmacology. 10. S147–S150. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by DA Richards Breakdown of academic impact, for papers by H Pirttiaho Breakdown of academic impact, for papers by Martin M.-T. Fuh Breakdown of academic impact, for papers by Ch. Schnack Breakdown of academic impact, for papers by Rafael Marín Breakdown of academic impact, for papers by Nicholas Alp Breakdown of academic impact, for papers by Nicole Jachmann Breakdown of academic impact, for papers by Frida Liane Plavnik Breakdown of academic impact, for papers by M.L. Muiesan Breakdown of academic impact, for papers by K McGarry
Rankless by CCL
2026